<qa>  What is the overall survival rate of the combination treatment?I. To characterize the safety and toxicity profile of the combination. II. To evaluate the clinical benefit rate no disease progression within 6 months, progression free survival PFS, and overall survival OS in patients receiving the combination treatment. 